The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Characterization of Apolipoprotein E-containing Lipoproteins in Cerebrospinal Fluid: Effect of Phenotype on the Distribution of Apolipoprotein E
Abstract
Background: Apolipoprotein (apo) E, one of the main apolipoproteins in the central nervous system, may play an important role in lipid metabolism; however, the details of its function are poorly understood. In this study, we characterized apoE-containing lipoproteins in cerebrospinal fluid (CSF) and examined the effect of apoE phenotype on the distribution of apoE among the lipoprotein fractions. Methods: CSF lipoproteins were fractionated by gel filtration and ultracentrifugation, and then characterized by electrophoresis, immunoblot, electron microscopy, and analysis of apoE, total cholesterol, and phospholipid concentrations. Results: The ratio of sialylated to nonsialylated apoE was higher in CSF than in serum. However, the fundamental forms containing apoE homodimers or heterodimers [such as apo(E-AII) and apo(AII-E2-AII) complexes] were similar in CSF and serum. apoE-containing lipoproteins were fractionated at densities of <1.006, 1.063–1.125, and 1.125–1.21 kg/L. Neither apoE nor apoAI was detected in the fraction with a density range of 1.006–1.063 kg/L. The diameters of the lipoprotein particles with densities of <1.006, 1.063–1.125, and 1.125–1.21 kg/L were 16.7 ± 3.1, 14.0 ± 3.2, and 11.6 ± 2.8 nm (mean ± SD, n = 200), respectively. All of these lipoproteins exhibited a spherical structure. The distribution profile of apoE-containing lipoproteins was affected by the apoE phenotype. A relatively large amount of apoE-containing lipoproteins was isolated from the fraction with a density >1.125 kg/L obtained from CSF associated with apoE2 or apoE3. This tendency was more obvious in CSF associated with apoE2 than in CSF without apoE2. apoE-containing lipoproteins were predominantly observed in the fraction with a density of <1.006 kg/L obtained from CSF associated with apoE4. Conclusions: The lipoproteins in CSF have a unique composition that is different from that of the lipoproteins in plasma. However, the differences in diameter between the CSF fractions were not as large as for the serum fractions. Our data suggest that the apoE phenotype may affect the distribution profile of apoE-containing lipoproteins in the CSF. This would mean that the metabolism of apoE-containing lipoproteins depends on the apoE isoform present.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The ApoE-ApoA2 heterodimer has been isolated in human CSF samples.
“The ApoE-ApoA2 heterodimer has also been isolated in human CSF samples [63, 138].”
From ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer’s disease and related disorders (2026) · cites this paper as [138]
Citations
Cites
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., & Taylor, J. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112130 · Cited by 829
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693
Isoform-specific binding of apolipoprotein E to beta-amyloid.
LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31529-6 · Cited by 540
Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.
Linton, M. F., Gish, R., Hubl, S. T., Bütler, E., Esquivel, C., Bry, W. I., Boyles, J. K., Wardell, M. R., & Young, S. G. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115288 · Cited by 367
Apolipoprotein J: structure and tissue distribution
De Silva, H. V., Harmony, J. A. K., Stuart, W. D., Gil, C. M., & Robbins, J. (1990) · Biochemistry · doi:10.1021/bi00474a025 · Cited by 353
Abnormal in vivo metabolism of apolipoprotein E4 in humans.
Gregg, R. E., Zech, L. A., Schaefer, E. J., Stark, D., Wilson, D., & Brewer, H. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112645 · Cited by 345
Weisgraber, K. H. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42621-5 · Cited by 304
Nascent astrocyte particles differ from lipoproteins in CSF
LaDu, M. J., Gilligan, S. M., Lukens, J. R., Cabana, V. G., Reardon, C. A., Van Eldik, L. J., & Holtzman, D. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052070.x · Cited by 285 · cited 2×
“Recently, CSF lipoproteins have been investigated by several groups, and their characterization has been progressing gradually (9, 10, 18).”
BackgroundResult
Flagged first, then by citations
Research works printed but not linked: 25
- 1988, Science, 240, 622, 10.1126/science.3283935 · DOI · Paper page
- 1989, Nature, 341, 162, 10.1038/341162a0 · DOI
- 1985, Proc Natl Acad Sci U S A, 82, 203, 10.1073/pnas.82.1.203 · DOI · Paper page
- 1979, Proc Natl Acad Sci U S A, 76, 4646, 10.1073/pnas.76.9.4646 · DOI · Paper page
- 1987, J Biol Chem, 262, 14352, 10.1016/S0021-9258(18)47945-8 · DOI · Paper page
- 1995, Biochim Biophys Acta, 1255, 192, 10.1016/0005-2760(94)00232-N · DOI
- 1988, Proc Natl Acad Sci U S A, 85, 9821, 10.1073/pnas.85.24.9821 · DOI
- 1991, Brain Res, 541, 163, 10.1016/0006-8993(91)91092-F · DOI · Paper page
- 1993, Proc Natl Acad Sci U S A, 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
- 1993, Lancet, 342, 737, 10.1016/0140-6736(93)91728-5 · DOI
- 1993, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
- 1993, Proc Natl Acad Sci U S A, 90, 8098, 10.1073/pnas.90.17.8098 · DOI · Paper page
- 1998, 060 g/mL in human cerebrospinal fluid. J Neurochem, 70, 1235
- 1989, Arteriosclerosis, 9, 405, 10.1161/01.ATV.9.3.405 · DOI · Paper page
- 1970, Nature, 227, 680, 10.1038/227680a0 · DOI · Paper page
- 1992, Biochim Biophys Acta, 1165, 61, 10.1016/0005-2760(92)90076-8 · DOI
- 1986, Clin Chem, 32, 1094
- 1999, Clin Chem, 45, 497, 10.1093/clinchem/45.4.497 · DOI
- 1991, Clin Chim Acta, 196, 167, 10.1016/0009-8981(91)90070-S · DOI
- 1991, J Biol Chem, 266, 12029, 10.1016/S0021-9258(18)99060-5 · DOI · Paper page
- 1978, J Biol Chem, 253, 6281, 10.1016/S0021-9258(17)34612-4 · DOI · Paper page
- 1984, J Lipid Res, 25, 58, 10.1016/S0022-2275(20)37844-5 · DOI
- 1989, J Biol Chem, 264, 21573, 10.1016/S0021-9258(20)88222-2 · DOI
- 1992, Int J Clin Lab Res, 21, 264, 10.1007/BF02591657 · DOI
- 1998, Alzheimer Dis Assoc Disord, 12, 198, 10.1097/00002093-199809000-00012 · DOI
Cited by
Sorted by citations
Transcytosis: Crossing Cellular Barriers
TUMA, P. L., & HUBBARD, A. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00001.2003 · Cited by 681
Strickland, M. R., & Holtzman, D. M. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00970-0
Metadata
- Authors
- Yamauchi, K., Tozuka, M., Hidaka, H., Hidaka, E., Kondo, Y., & Katsuyama, T.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-09-01
- Volume
- 45
- Issue
- 9
- Pages
- 1431-1438
- ISSN
- 0009-9147
- 1530-8561
- Cited by
- 41
- References
- 9
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review